ALB and schizophrenia: Several acute phase proteins (A2M, C3, SERPINA1, and ALB), proposed as candidate biomarkers for schizophrenia, were also found to be associated with Parkinson's disease, Alzheimer's disease, and MDD (Chiam et al., 2015).